Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma

Drug resistance and disease recurrence are important contributors for the poor prognosis of glioblastoma multiforme (GBM). Temozolomide (TMZ), the standard chemotherapy for GBM treatment, can methylate DNA and cause the formation of double-strand breaks (DSBs). X-ray repair cross complementing 5 (XR...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, I-Neng, Yang, Jen-Tsung, Huang, Cheng, Huang, Hsiu-Chen, Wu, Yu-Ping, Chen, Jui-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045174/
https://www.ncbi.nlm.nih.gov/pubmed/33868481
http://dx.doi.org/10.3892/ol.2021.12704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045174/
https://www.ncbi.nlm.nih.gov/pubmed/33868481
http://dx.doi.org/10.3892/ol.2021.12704

Ejemplares similares